Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.22% | 2.04% | -25.99% | -4.46% | -10.93% |
| Total Depreciation and Amortization | 2.20% | 3.18% | 3.29% | -37.72% | -68.19% |
| Total Amortization of Deferred Charges | 1.59% | 1.21% | 1.22% | 1.66% | 1.26% |
| Total Other Non-Cash Items | 211.82% | -78.85% | 1,232.87% | 345.04% | -114.67% |
| Change in Net Operating Assets | 153.86% | -211.06% | 130.63% | -190.23% | 38.62% |
| Cash from Operations | 19.86% | -33.59% | 23.15% | -18.47% | -11.96% |
| Capital Expenditure | -- | -- | 100.00% | -103.85% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.13% | 329.98% | -61.49% | 100.01% | -58.49% |
| Cash from Investing | -43.13% | 329.98% | -61.44% | 100.01% | -58.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.05% | 111.27% | 1,891.49% | -81.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.05% | 111.27% | 1,891.49% | -81.35% | -- |
| Foreign Exchange rate Adjustments | -5,150.00% | 102.11% | -173.64% | 22.86% | 184.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.56% | 265.74% | -540.71% | 84.10% | -196.84% |